ATE39686T1 - Dopamin-beta-hydroxylase inhibitoren. - Google Patents
Dopamin-beta-hydroxylase inhibitoren.Info
- Publication number
- ATE39686T1 ATE39686T1 AT84302422T AT84302422T ATE39686T1 AT E39686 T1 ATE39686 T1 AT E39686T1 AT 84302422 T AT84302422 T AT 84302422T AT 84302422 T AT84302422 T AT 84302422T AT E39686 T1 ATE39686 T1 AT E39686T1
- Authority
- AT
- Austria
- Prior art keywords
- dopamine beta
- hydroxylase inhibitors
- beta hydroxylase
- 4alkyl
- och3
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
- C07C217/62—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/484,123 US4532331A (en) | 1983-04-12 | 1983-04-12 | 1-Benzyl-2-aminomethyl imidazole derivatives |
EP84302422A EP0125783B1 (de) | 1983-04-12 | 1984-04-10 | Dopamin-beta-hydroxylase Inhibitoren |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE39686T1 true ATE39686T1 (de) | 1989-01-15 |
Family
ID=23922842
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT84302422T ATE39686T1 (de) | 1983-04-12 | 1984-04-10 | Dopamin-beta-hydroxylase inhibitoren. |
Country Status (12)
Country | Link |
---|---|
US (1) | US4532331A (de) |
EP (1) | EP0125783B1 (de) |
JP (1) | JPS59199678A (de) |
AT (1) | ATE39686T1 (de) |
AU (1) | AU575558B2 (de) |
CA (1) | CA1223598A (de) |
DE (1) | DE3475905D1 (de) |
DK (3) | DK162629C (de) |
ES (2) | ES8602686A1 (de) |
GR (2) | GR79885B (de) |
IE (1) | IE57234B1 (de) |
PT (1) | PT78389B (de) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT78388B (en) * | 1983-04-12 | 1986-09-15 | Smithkline Beckman Corp | Dopamine-beta-hydroxylase inhibitors |
US4992459A (en) * | 1983-04-12 | 1991-02-12 | Smithkline Beecham Corporation | Dopamine-β-hydroxylase inhibitors |
EP0149976A3 (de) * | 1983-12-30 | 1986-12-10 | Ciba-Geigy Ag | Substituierte Imidazole |
JPS61110266A (ja) * | 1984-11-05 | 1986-05-28 | Omron Tateisi Electronics Co | カード発行方法 |
US4634711A (en) * | 1985-08-02 | 1987-01-06 | Smithkline Beckman Corporation | Pyridylalkyl imidazole-2-thiols |
US4719223A (en) * | 1985-10-31 | 1988-01-12 | Smithkline Beckman Corporation | Imidazolethiol dopamine-beta-hydroxylase inhibitors |
US4743613A (en) * | 1986-04-08 | 1988-05-10 | Smithkline Beckman Corporation | Ester prodrugs of dopamine-β-hydroxylase, inhibitors, composition containing them, and method of using them to inhibit dopamine-β-hydroxylase activity |
IL82401A0 (en) * | 1986-05-06 | 1987-11-30 | Merrell Dow Pharma | Dopamine beta hydroxy-lase inhibiting imidazole derivatives and pharmaceutical compositions containing them |
US5138069A (en) * | 1986-07-11 | 1992-08-11 | E. I. Du Pont De Nemours And Company | Angiotensin II receptor blocking imidazoles |
NZ221427A (en) * | 1986-08-18 | 1990-12-21 | Smithkline Beckman Corp | 2-mercaptoimidazole derivatives and pharmaceutical compositions |
US4761415A (en) * | 1986-08-28 | 1988-08-02 | Smithkline Beckman Corporation | Dopamine-β-hydroxylase inhibitors |
US4996221A (en) * | 1987-01-13 | 1991-02-26 | The Board Of Trustees Of The Leland Stanford Junior University | Histamine derivatives as immune modulators |
US4762850A (en) * | 1987-03-24 | 1988-08-09 | Smithkline Beckman Corporation | Dopamine-beta-hydroxylase inhibitors |
US4859779A (en) * | 1987-03-24 | 1989-08-22 | Smithkline Beckman Corporation | Dopamine-β-hydroxylase inhibitors |
US4835154A (en) * | 1987-06-01 | 1989-05-30 | Smithkline Beckman Corporation | 1-aralykyl-5-piperazinylmethyl-2-mercaptoimidazoles and 2-alkylthioimidazoles and their use as dopamine-βhydroxylase inhibitors |
US4839371A (en) * | 1987-09-17 | 1989-06-13 | Smithkline Beckman Corporation | 3-aralkyl-2-mercaptoyridines as dopamine-β-hydroxylase inhibitors |
US4935438A (en) * | 1987-12-29 | 1990-06-19 | Smithkline Beckman Corporation | Dopamine-β-hydroxylase inhibitors |
US4882348A (en) * | 1987-12-29 | 1989-11-21 | Smithkline Beckman Corporation | 2-(aminoalkylthio)imidazoles as dopamine-β-hydroxylase inhibitors |
US4876266A (en) * | 1987-12-31 | 1989-10-24 | Smithkline Beckman Corporation | 1-aralkyl-2-mercaptoimidazolines as DBH inhibitors |
CA1338238C (en) * | 1988-01-07 | 1996-04-09 | David John Carini | Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids |
US4880804A (en) * | 1988-01-07 | 1989-11-14 | E. I. Du Pont De Nemours And Company | Angiotensin II receptor blocking benzimidazoles |
DK440989A (da) * | 1988-09-12 | 1990-03-13 | Smithkline Beecham Corp | Dopamin-beta-hydroxylase inhibitorer |
US5354867A (en) * | 1988-12-06 | 1994-10-11 | E. I. Du Pont De Nemours And Company | Angiotensin II receptor blocking imidazoles |
KR950009860B1 (ko) * | 1989-06-30 | 1995-08-29 | 이. 아이. 듀퐁 드 네모아 앤드 캄파니 | 융합된 환 아릴 치환된 이미다졸과 약제학적으로 허용되는 이의 염, 이들의 제조방법 및 이들을 함유하는 약제학적 조성물 |
CA2032289A1 (en) * | 1989-12-29 | 1991-06-30 | Joseph A. Finkelstein | Substituted 5-(alkyl) carboxamide imidazoles |
GB9010366D0 (en) * | 1990-05-09 | 1990-06-27 | Smith Kline French Lab | Medicaments |
WO1993014753A1 (en) * | 1992-01-27 | 1993-08-05 | The Board Of Trustees Of The Leland Stanford Junior University | Histamine derivatives and methods for their use |
WO2006107923A1 (en) * | 2005-04-05 | 2006-10-12 | Boehringer Ingelheim International Gmbh | Substituted benzylimidazoles useful for the treatment of inflammatory diseases |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL6614808A (de) * | 1965-10-21 | 1967-04-24 | ||
BE793407A (fr) * | 1971-12-28 | 1973-06-28 | Hoechst Ag | Imidazolyl - (2) -carbinols ayant une activite hypolipidemique et leur procede de preparation |
DE2259627A1 (de) * | 1972-12-06 | 1974-06-12 | Hoechst Ag | Imidazolyl-(2)-thio-alkansaeureester und verfahren zu ihrer herstellung |
CA1028331A (en) * | 1973-01-24 | 1978-03-21 | Michio Nakanishi | Imidazole compounds |
JPS5069078A (en) * | 1973-01-24 | 1975-06-09 | Yoshitomi Pharmaceutical | Shinkinaimidazoorujudotai no seizoho |
FI803127L (fi) * | 1979-10-03 | 1981-04-04 | Glaxo Group Ltd | Heterocykliska foereningar |
GB2096987B (en) * | 1981-04-22 | 1984-04-04 | Farmos Oy | Substituted imidazole and imidazole derivatives and their preparation and use |
PT78388B (en) * | 1983-04-12 | 1986-09-15 | Smithkline Beckman Corp | Dopamine-beta-hydroxylase inhibitors |
-
1983
- 1983-04-12 US US06/484,123 patent/US4532331A/en not_active Expired - Fee Related
-
1984
- 1984-04-09 PT PT78389A patent/PT78389B/pt not_active IP Right Cessation
- 1984-04-10 AT AT84302422T patent/ATE39686T1/de active
- 1984-04-10 IE IE875/84A patent/IE57234B1/en unknown
- 1984-04-10 DE DE8484302422T patent/DE3475905D1/de not_active Expired
- 1984-04-10 EP EP84302422A patent/EP0125783B1/de not_active Expired
- 1984-04-11 GR GR74382A patent/GR79885B/el unknown
- 1984-04-11 AU AU26722/84A patent/AU575558B2/en not_active Ceased
- 1984-04-11 GR GR74375A patent/GR79907B/el unknown
- 1984-04-11 CA CA000451719A patent/CA1223598A/en not_active Expired
- 1984-04-12 DK DK190284A patent/DK162629C/da not_active IP Right Cessation
- 1984-04-12 JP JP59074801A patent/JPS59199678A/ja active Pending
- 1984-04-12 ES ES531552A patent/ES8602686A1/es not_active Expired
-
1985
- 1985-01-15 ES ES539565A patent/ES8601909A1/es not_active Expired
-
1991
- 1991-05-24 DK DK91996A patent/DK99691D0/da not_active Application Discontinuation
- 1991-05-24 DK DK91997A patent/DK99791D0/da not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DK162629C (da) | 1992-04-13 |
EP0125783A1 (de) | 1984-11-21 |
CA1223598A (en) | 1987-06-30 |
PT78389B (en) | 1986-09-15 |
IE57234B1 (en) | 1992-06-17 |
IE840875L (en) | 1984-10-12 |
EP0125783B1 (de) | 1989-01-04 |
DK190284D0 (da) | 1984-04-12 |
ES531552A0 (es) | 1985-12-01 |
GR79907B (de) | 1984-10-31 |
US4532331A (en) | 1985-07-30 |
ES539565A0 (es) | 1985-11-01 |
ES8601909A1 (es) | 1985-11-01 |
DK99691A (da) | 1991-05-24 |
DK99791A (da) | 1991-05-24 |
JPS59199678A (ja) | 1984-11-12 |
GR79885B (de) | 1984-10-31 |
DE3475905D1 (en) | 1989-02-09 |
DK162629B (da) | 1991-11-25 |
ES8602686A1 (es) | 1985-12-01 |
PT78389A (en) | 1984-05-01 |
AU2672284A (en) | 1984-10-18 |
AU575558B2 (en) | 1988-08-04 |
DK190284A (da) | 1984-10-13 |
DK99791D0 (da) | 1991-05-24 |
DK99691D0 (da) | 1991-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE39686T1 (de) | Dopamin-beta-hydroxylase inhibitoren. | |
MY102519A (en) | Dopamine ?-hydroxylase inhibitors | |
CY1252A (en) | (piperidinylalkyl)quinazoline derivatives and intermediates,process for their preparation and pharmaceutical compositions containing them | |
SE8200916L (sv) | Karbostyrilderivat, forfarande for framstellning derav och hjertsterkande komposition som innehaller detsamma | |
JPS5665869A (en) | Novel 22hydroxyalkyll3*4*55trihydroxyypiperidine compound* its manufacture and drug | |
GR1000460B (el) | Μεθοδος παρασκευης παραγωγων καψαικινης. | |
ATE13423T1 (de) | Guanidinderivate und diese enthaltende pharmazeutische zusammensetzungen. | |
ATE78163T1 (de) | Stickstoff enthaltende heterozyklische verbindungen. | |
ES458719A1 (es) | Un procedimiento para la preparacion de nuevos derivados de urazol 1,2,4-sustituidos. | |
ES8203870A1 (es) | Procedimiento para preparar difenilbutil-1-acilpiperazinas | |
ES8304915A1 (es) | Procedimiento para la obtencion de derivados de dioxibencenoeteres. | |
FI845095L (fi) | Aminoimidazolonderivat saosom histamin-h2-antagonister. | |
FI864737A (fi) | Nya basiskt substituerade pyridinfoereningar, foerfaranden foer deras framstaellning, dessa innehaollande laekemedel och deras anvaendning. | |
NO166125C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aroyl-substituerte dihydro-1,4-tiaziner. | |
SE8701524D0 (sv) | Nya sulfonamider och deras framstellningsforfarande | |
FR2360593A1 (fr) | Derives de triazolobenzazepine et compositions pharmaceutiques les contenant | |
DE3370627D1 (de) | Acridanone derivatives | |
ES8201994A1 (es) | Procedimiento para la obtencion de nuevos derivados piridi- nicos de interes farmacologico |